Beschrijving
Mitophagy sounds technical — until you realize it may be one of the most important biological processes behind aging, cardiovascular disease, eye degeneration, inflammation, and cellular energy. In this episode, Dr. Mike and Don break down three recent scientific reviews that converge on one central message: when mitochondrial cleanup fails, tissues don’t just lose ATP — they become inflamed, oxidatively stressed, and vulnerable to disease. You’ll learn the difference between autophagy and mitophagy, why damaged mitochondria act like inflammatory “danger beacons,” what this looks like in Fabry disease cardiomyopathy, inflammatory cardiovascular disease, and ophthalmic diseases like glaucoma/AMD/diabetic retinopathy — and why the future of mitochondrial medicine is about restoring the rhythm of removal + renewal.
(Educational content only, not medical advice.)
-
Articles Referenced in Episode:
Mitophagy in ophthalmic pathologies: Molecular mechanisms and therapeutic implications
Understanding Dysfunctional Autophagy and Mitophagy in Inflammatory Cardiovascular Disease
Early mitophagy defects and impaired mitochondrial energy metabolism drive target organ damage progression: lessons from the Fabry heart
-
Key Quotes From Episode:
“Mitophagy… means the body’s process for identifying damaged mitochondria, removing them, and making room for healthier mitochondria to take their place.”
“When mitochondrial cleanup fails, the cell doesn’t just lose energy — it becomes inflamed, stressed, and vulnerable to disease.”
"Mitochondrial quality control is not a side issue. It may be one of the central mechanisms that determines whether high-demand tissues stay resilient or begin to fail.”
“A healthy cell is always asking: which mitochondria are still efficient, and which ones are leaking too much oxidative stress?”
“Mitophagy is the process that removes the liabilities.”
“Damaged mitochondria are not just weak energy producers. They can actually become inflammatory.”
-
Key Points
Autophagy = general cellular recycling; mitophagy = targeted recycling of damaged mitochondria.
Mitochondria are dynamic networks, not static “batteries” — they’re constantly tested, repaired, fused/fissioned, and removed.
Damaged mitochondria don’t just make less ATP—they can trigger sterile inflammation by leaking ROS, mtDNA, cardiolipin, etc.
Fabry disease heart model: lysosomal dysfunction → impaired mitophagy → damaged mitochondria → less ATP + more ROS → worse lysosome function (a mito–lysosomal vicious cycle).
Inflammatory cardiovascular disease: damaged mitochondria activate inflammatory pathways (e.g., NLRP3) and worsen vascular/heart pathology.
Ophthalmology: retina is extremely energy-hungry; mitophagy failure contributes to glaucoma/AMD/diabetic retinopathy vulnerability.
Shared “cast” across tissues: PINK1/Parkin, BNIP3/NIX/FUNDC1, AMPK–mTOR, sirtuins, FOXO3, PGC-1α(cleanup + rebuilding).
The winning strategy isn’t “maximize mitophagy” — it’s balanced flux: remove…
Website: theenergycode.podbean.com

